Abstract:Objective: To investigate the clinical significance of suppressor of cytokine signaling 1 (SOCS1) hypermethylation in typical myelo-proliferative neoplasms (MPNs), and to discuss the potential mechanism. Methods: Methylation specific PCR was used to detect the hypermethylation status of SOCS1 gene in bone marrow specimens from patients with typical MPNs. Granulocyte colony stimulating factor (G-CSF) was used as a chemical inducer to simulate the MPNs cells for different time, then the real-time quantitative PCR and Western blotting were applied to evaluate the expressions of SOCS1 mRNA and protein, respectively. After the demethylating agent 2-deoxyazacytidin was used to cultivate MPNs cells for different time, SOCS1 mRNA expression was detected by real-time quantitative PCR. Results: Hypermethylation of SOCS1 was detected in 27 of 100 (27.0%) cases of MPNs. The expressions of SOCS1 mRNA in the MPNs cells were significantly decreased after G-CSF intervention in the SOCS1 hypermethylation groups as compared with those in the non-methylation groups (P0.05). The expressions of SOCS1 protein in the SOCS1 hypermethylation groups from patients with MPNs were decreased, but there was no statistically significant difference as compared with normal controls (P0.05). In addition, SOCS1 mRNA expression was markedly promoted in MPNs cells after treatment with the demethylating agent as compared with the hypermethylated groups induced by G-CSF The roles of hypermethylation and demethylation of suppressor of cytokine signaling 1 gene in typical myelo-proliferative neoplasms QIN Wei, LU Hui-na, HUANG Bin-bin, XIU Bing, BO Lan-jun, GAO Qing-mei, ZHANG Wen-jun, LIANG Ai-bin Department of Hematology, Tongji Hospital, Tongji University, Shanghai 200065, China Abstract Objective: To investigate the clinical significance of suppressor of cytokine signaling 1 (SOCS1) hypermethylation in typical myelo-proliferative neoplasms (MPNs), and to discuss the potential mechanism. Methods: Methylation specific PCR was used to detect the hypermethylation status of SOCS1 gene in bone marrow specimens from patients with typical MPNs. Granulocyte colony stimulating factor (G-CSF) was used as a chemical inducer to simulate the MPNs cells for different time, then the real-time quantitative PCR and Western blotting were applied to evaluate the expressions of SOCS1 mRNA and protein, respectively. After the demethylating agent 2-deoxyazacytidin was used to cultivate MPNs cells for different time, SOCS1 mRNA expression was detected by real-time quantitative PCR. Results: Hypermethylation of SOCS1 was detected in 27 of 100 (27.0%) cases of MPNs. The expressions of SOCS1 mRNA in the MPNs cells were significantly decreased after G-CSF intervention in the SOCS1 hypermethylation groups as compared with those in the non-methylation groups (P0.05). The expressions of SOCS1 protein in the SOCS1 hypermethylation groups from patients with MPNs were decreased, but there was no statistically significant difference as compared with normal controls (P0.05). In addition, SOCS1 mRNA expression was markedly promoted in MPNs cells after treatment with the demethylating agent as compared with the hypermethylated groups induced by G-CSF (P0.05). Conclusion: Hypermethylation of SOCS1 exists in MPNs, and the hypermethylation of CpG can inhibit the expression of SOCS1 gene. After demethylation, the expression of SOCS1 gene increases in MPNs. These suggest that the SOCS1 hypermethylation may be associated with the risk of MPNs. Demethylation may become a potential therapeutic strategy for MPNs.

Promoter Region Methylation of SOCS-1 and RIZ1 Genes in Gastric Cancer

Promoter Hypermethylation of SOCS-1 in Gastric Cancer

Association of Abnormal Methylation of CpG Islands in Promoter Domains of Multiple Tumor Suppressor Genes with Non-Small Cell Lung Cancer

Methylomics Analysis Identifies a Putative STAT3 Target, SPG20, As a Noninvasive Epigenetic Biomarker for Early Detection of Gastric Cancer

Aberrant methylation of suppressor of cytokine signaling-1 gene in human pancreatic ductal carcinomas

Aberrant Promoter Methylation of SOCS-1 Gene May Contribute to the Pathogenesis of Hepatocellular Carcinoma: a Meta-Analysis.

Methylation and Demethylation of SOX2 Gene Promoter in BGC-823 Gastric Cancer Cells

Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.

Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis

The roles of hypermethylation and demethylation of suppressor of cytokine signaling 1 gene in typical myelo-proliferative neoplasms

Methylation of ras association domain protein 10 (RASSF10) promoter negative association with the survival of gastric cancer.

Poor Survival is Associated with the Methylated Degree of Zinc-Finger Protein 545 (znf545) Dna Promoter in Gastric Cancer

Study on Riz1 Gene Promoter Methylation Status in Human Esophageal Squamous Cell Carcinoma

Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases

Association of Diminished Expression of RASSF1A with Promoter Methylation in Primary Gastric Cancer from Patients of Central China.

Detection of Serum RASSF1A Gene Promoter Methylation in Patients with Gastric Cancer

Prognostic Significance of Aberrant Gene Methylation in Gastric Cancer.

[Promoter Region Methylation of DNA Damage Repair Genes in Human Gastric Cancer].

Effect of the SOCS3 expression activates IL-6/STAT3 signal pathway via Abnormal methylation alteration of IL-6 in colorectal cancer

Six1 gene promoter's methylation in gastric cancer and its value for evaluating the disease condition and prognosis

Low Expression of SOCS-1 and SOCS-3 is a Poor Prognostic Indicator for Gastric Cancer Patients.